Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00957073 · ClinicalTrials.gov registry record · NA
Rheos System for the Treatment of HFpEF Heart Failure
A NA study, sponsored by CVRx.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT00957073: Completed NA study, sponsored by CVRx.
NCT00957073 is a NA study that has completed, run by CVRx. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00957073, a NA study, has completed, sponsored by CVRx.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this clinical investigation (NCT00957073) is to continue long-term follow-up of device arm subjects enrolled in the HOPE4HF Trial, utilizing the BAROSTIM NEO™ LEGACY device for Implantable Pulse Generator (IPG) replacements.
Interventions
- DEVICE Rheos® system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2009-08 |
| Est. Completion | 2021-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00957073
The ClinicalTrials.gov registry entry for NCT00957073 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CVRx, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rheos® system is the first listed.
NCT00957073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00957073 about?
NCT00957073 is a clinical study titled "Rheos System for the Treatment of HFpEF Heart Failure". The purpose of this clinical investigation (NCT00957073) is to continue long-term follow-up of device arm subjects enrolled in the HOPE4HF Trial, utilizing the BAROSTIM NEO™ LEGACY device for Implantable Pulse Generator (IPG) replacements.
What is the current status of trial NCT00957073?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2009-08. Estimated completion is 2021-04-01.
What interventions are being tested in trial NCT00957073?
The interventions under investigation include: Rheos® system (DEVICE).
Who is sponsoring clinical trial NCT00957073?
This trial is sponsored by CVRx, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.